news
The experimental drug TEMPOL has demonstrated antiviral activity against COVID-19…
8 June 2021 | By Victoria Rees (Drug Target Review)
The experimental drug TEMPOL has demonstrated antiviral activity against COVID-19 in a pre-clinical study in cell cultures.